ArticleACS applied materials & interfaces2025
From Wound Dressing to Tissue Regeneration: Bilayer Medicated Patches for Personalized Treatments of Chronic Wounds.
Article in ACS applied materials & interfaces, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Evaluating 3D-Patch Efficacy in Wound Healing Using the Medicinal LeechNanomaterials (Basel, Switzerland) · 2026Article
- Biofilm-Responsive Nanoplatforms for Infected Wound Reconstruction.International journal of nanomedicine · 2026Review
- Emerging Nanomaterials Can Even Treat Chronic Wounds: A Review of Evidence on Magnesium-Based Systems.International journal of nanomedicine · 2026Review
- Nanostructured Scaffold, Combined with Human Dental Pulp Stem Cell Secretome, Induces Vascularization in Medicinal Leech Model.Micromachines · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Chronic wounds pose a significant healthcare challenge, impairing the quality of life for millions of affected individuals. This phenomenon escalates due to the aging of the population and rising comorbidities. Traditional wound care methods often prove inadequate in dealing with the complexities of chronic wounds; therefore, biomaterials have emerged as promising solutions. In response to this need, this work focuses on the development of a bilayered hybrid patch for the treatment of chronic wounds, designed with a chemical composition and morphology to exert antimicrobial activity to combat local infection and to provide specific support for cell adhesion and tissue regeneration. In particular, using gelatin and chitosan as the main constituent materials, bioactive membranes were developed and functionalized with bioresorbable hydroxyapatite nanoparticles doped with magnesium ions grown on gelatin molecules to boost regenerative stimuli. Then, they were assembled into a bilayered structure with highly tuned chemical and structural features through different fabrication techniques and biodegradation by cross-linking processes. Lastly, to confer antibacterial properties, the lower layer was medicated in situ with Vancomycin hydrochloride (VNC), selected as a case study antibiotic. The developed patches exhibit excellent physiochemical properties, including exudate absorption and moisture permeability, with both features falling within the recommended range for materials for wound healing applications. In addition, both patches exhibit adequate biodegradation times to support effective cell adhesion and proliferation, as well as drug release kinetics, with almost complete release of VNC after 48 h, necessary to achieve thorough wound disinfection. In vitro biological studies have proved their biocompatibility and on-site, long-lasting antimicrobial potential, while in vivo tests, with medicinal leeches' model, have demonstrated their affinity for live tissue and efficacy in supporting endothelial cell proliferation by stimulating the epidermal tissue healing process.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.